| Characterization of peptides bound to the class I MHC molecule HLA-A2. 1 by mass spectrometry DF Hunt, RA Henderson, J Shabanowitz, K Sakaguchi, H Michel, N Sevilir, ... Science 255 (5049), 1261-1263, 1992 | 1658 | 1992 |
| Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines AL Cox, J Skipper, Y Chen, RA Henderson, TL Darrow, J Shabanowitz, ... Science 264 (5159), 716-719, 1994 | 1142 | 1994 |
| HLA-A2. 1-associated peptides from a mutant cell line: a second pathway of antigen presentation RA Henderson, H Michel, K Sakaguchi, J Shabanowitz, E Appella, ... Science 255 (5049), 1264-1266, 1992 | 689 | 1992 |
| Activation of human dendritic cells following infection with Mycobacterium tuberculosis. RA Henderson, SC Watkins, JL Flynn Journal of immunology (Baltimore, Md.: 1950) 159 (2), 635-643, 1997 | 589 | 1997 |
| MUC-1 epithelial tumor mucin-based immunity and cancer vaccines. OJ Finn, KR Jerome, RA Henderson, G Pecher, N Domenech, ... Immunological reviews 145, 61-89, 1995 | 357 | 1995 |
| Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling. EL Huczko, WM Bodnar, D Benjamin, K Sakaguchi, NZ Zhu, ... Journal of immunology (Baltimore, Md.: 1950) 151 (5), 2572-2587, 1993 | 221 | 1993 |
| Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumor antigen mucin. N Domenech, RA Henderson, OJ Finn Journal of immunology (Baltimore, Md.: 1950) 155 (10), 4766-4774, 1995 | 205 | 1995 |
| Direct identification of an endogenous peptide recognized by multiple HLA-A2. 1-specific cytotoxic T cells. RA Henderson, AL Cox, K Sakaguchi, E Appella, J Shabanowitz, DF Hunt, ... Proceedings of the National Academy of Sciences 90 (21), 10275-10279, 1993 | 178 | 1993 |
| Recognition of human melanoma cells by HLA-A2. 1-restricted cytotoxic T lymphocytes is mediated by at least six shared peptide epitopes. CL Slingluff Jr, AL Cox, RA Henderson, DF Hunt, VH Engelhard Journal of immunology (Baltimore, Md.: 1950) 150 (7), 2955-2963, 1993 | 178 | 1993 |
| Human dendritic cells genetically engineered to express high levels of the human epithelial tumor antigen mucin (MUC-1) RA Henderson, MT Nimgaonkar, SC Watkins, PD Robbins, ED Ball, ... Cancer research 56 (16), 3763-3770, 1996 | 171 | 1996 |
| Naturally processed peptides longer than nine amino acid residues bind to the class I MHC molecule HLA-A2. 1 with high affinity and in different conformations. YE Chen, J Sidney, S Southwood, AL Cox, K Sakaguchi, RA Henderson, ... Journal of immunology (Baltimore, Md.: 1950) 152 (6), 2874-2881, 1994 | 168 | 1994 |
| Development of a recombinant HSP110-HER-2/neu vaccine using the chaperoning properties of HSP110 MH Manjili, R Henderson, XY Wang, X Chen, Y Li, E Repasky, L Kazim, ... Cancer research 62 (6), 1737-1742, 2002 | 135 | 2002 |
| HSP110-HER2/neu chaperone complex vaccine induces protective immunity against spontaneous mammary tumors in HER-2/neu transgenic mice MH Manjili, XY Wang, X Chen, T Martin, EA Repasky, R Henderson, ... The Journal of Immunology 171 (8), 4054-4061, 2003 | 131 | 2003 |
| Human tumor antigens are ready to fly RA Henderson, OJ Finn Advances in immunology 62, 217-256, 1996 | 131 | 1996 |
| Compositions and methods for the therapy and diagnosis of prostate cancer J Xu, DC Dillon, JL Mitcham, SL Harlocker, Y Jiang, MD Kalos, GR Fanger, ... US Patent 6,800,746, 2004 | 114 | 2004 |
| MUC1 and other sialoglycoconjugates inhibit adenovirus-mediated gene transfer to epithelial cells SM Arcasoy, J Latoche, M Gondor, SC Watkins, RA Henderson, ... American journal of respiratory cell and molecular biology 17 (4), 422-435, 1997 | 113 | 1997 |
| Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma-associated antigen gp100 XY Wang, X Chen, MH Manjili, E Repasky, R Henderson, JR Subjeck Cancer research 63 (10), 2553-2560, 2003 | 111 | 2003 |
| Reinvestigation of the role of the optic vesicle in embryonic lens induction RM Grainger, JJ Henry, RA Henderson Development 102 (3), 517-526, 1988 | 83 | 1988 |
| Compositions and methods for the therapy and diagnosis of prostate cancer J Xu, D Dillon, J Mitcham, S Harlocker, Y Jiang, R Henderson, M Kalos, ... US Patent App. 10/144,678, 2003 | 68 | 2003 |
| Cancer vaccines and immunotherapies: emerging perspectives RA Henderson, S Mossman, N Nairn, MA Cheever Vaccine 23 (17-18), 2359-2362, 2005 | 56 | 2005 |
